Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Black Americans have a higher likelihood of having asthma-COPD overlap syndrome (ACOS) but may not know it. Here’s what you ...

And according to the WHO, COPD is the fourth leading cause of death worldwide ... “WIN378, with its best-in-class potential ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children.

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, antibiotics and other drugs to manage the sometimes debilitating symptoms. However, ...

The Company continues to anticipate that the totality of its early-stage research programs will comprise less than 20% of overall expenditure.

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.